Atazanavir Capsules
- Manufacturer
- Zydus Lifesciences Limited
- Effective date
- 2022-10-13
- Label type
- HUMAN PRESCRIPTION DRUG LABEL
- Version
- 2
- Source
- legacy-cache
- Hydrated at
- 2026-08-01 21:51:33
Label at a glance#
Label contents#
Full prescribing information#
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 70771-1591 | ATAZANAVIR CAPSULE [ZYDUS LIFESCIENCES LIMITED] | 2 | Legacy NDC | 20221015_59417e87-cf46-4db6-975b-daf9c921098f.zip |
| 70771-1592 | ATAZANAVIR CAPSULE [ZYDUS LIFESCIENCES LIMITED] | 2 | Legacy NDC | 20221015_59417e87-cf46-4db6-975b-daf9c921098f.zip |
| 70771-1593 | ATAZANAVIR CAPSULE [ZYDUS LIFESCIENCES LIMITED] | 2 | Legacy NDC | 20221015_59417e87-cf46-4db6-975b-daf9c921098f.zip |
Products#
Every source-derived product name is available through these pages.
- ATAZANAVIR
- ATAZANAVIR SULFATE
- LACTOSE MONOHYDRATE
- CELLULOSE, MICROCRYSTALLINE
- CROSPOVIDONE
- TALC
- MAGNESIUM STEARATE
- TITANIUM DIOXIDE
- GELATIN
- FD&C BLUE NO. 1
- D&C RED NO. 28
- FD&C RED NO. 40
- D&C YELLOW NO. 10
- FERROSOFERRIC OXIDE
- BUTYL ALCOHOL
- ALCOHOL
- ISOPROPYL ALCOHOL
- POTASSIUM HYDROXIDE
- PROPYLENE GLYCOL
- WATER
- SHELLAC
- AMMONIA
- FERRIC OXIDE YELLOW
- FERRIC OXIDE RED
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 70771-1591 | 70771-1591-6, 70771-1591-1 |
| 70771-1592 | 70771-1592-6, 70771-1592-1 |
| 70771-1593 | 70771-1593-3, 70771-1593-1 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Orange Book application contexts#
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A210575-001 | ATAZANAVIR SULFATE | ATAZANAVIR SULFATE | EQ 150MG BASE | CAPSULE / ORAL | 2020-06-04 | ||
| A210575-002 | ATAZANAVIR SULFATE | ATAZANAVIR SULFATE | EQ 200MG BASE | CAPSULE / ORAL | 2020-06-04 | ||
| A210575-003 | ATAZANAVIR SULFATE | ATAZANAVIR SULFATE | EQ 300MG BASE | CAPSULE / ORAL | 2020-06-04 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-10-15 13:18:30 | 2026-09 | A210575-001 | ATAZANAVIR SULFATE | EQ 150MG BASE | CAPSULE / ORAL | 2020-06-04 | c2088c7a36db… | ||
| 2026-10-15 13:18:30 | 2026-09 | A210575-002 | ATAZANAVIR SULFATE | EQ 200MG BASE | CAPSULE / ORAL | 2020-06-04 | c2088c7a36db… | ||
| 2026-10-15 13:18:30 | 2026-09 | A210575-003 | ATAZANAVIR SULFATE | EQ 300MG BASE | CAPSULE / ORAL | 2020-06-04 | c2088c7a36db… | ||
| 2026-09-14 22:38:34 | 2026-08 | A210575-001 | ATAZANAVIR SULFATE | EQ 150MG BASE | CAPSULE / ORAL | 2020-06-04 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A210575-002 | ATAZANAVIR SULFATE | EQ 200MG BASE | CAPSULE / ORAL | 2020-06-04 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A210575-003 | ATAZANAVIR SULFATE | EQ 300MG BASE | CAPSULE / ORAL | 2020-06-04 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A210575-001 | ATAZANAVIR SULFATE | EQ 150MG BASE | CAPSULE / ORAL | 2020-06-04 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A210575-002 | ATAZANAVIR SULFATE | EQ 200MG BASE | CAPSULE / ORAL | 2020-06-04 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A210575-003 | ATAZANAVIR SULFATE | EQ 300MG BASE | CAPSULE / ORAL | 2020-06-04 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A210575-001 | ATAZANAVIR SULFATE | EQ 150MG BASE | CAPSULE / ORAL | 2020-06-04 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A210575-002 | ATAZANAVIR SULFATE | EQ 200MG BASE | CAPSULE / ORAL | 2020-06-04 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A210575-003 | ATAZANAVIR SULFATE | EQ 300MG BASE | CAPSULE / ORAL | 2020-06-04 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A210575-001 | ATAZANAVIR SULFATE | EQ 150MG BASE | CAPSULE / ORAL | 2020-06-04 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A210575-002 | ATAZANAVIR SULFATE | EQ 200MG BASE | CAPSULE / ORAL | 2020-06-04 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A210575-003 | ATAZANAVIR SULFATE | EQ 300MG BASE | CAPSULE / ORAL | 2020-06-04 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A210575-001 | ATAZANAVIR SULFATE | EQ 150MG BASE | CAPSULE / ORAL | 2020-06-04 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A210575-002 | ATAZANAVIR SULFATE | EQ 200MG BASE | CAPSULE / ORAL | 2020-06-04 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A210575-003 | ATAZANAVIR SULFATE | EQ 300MG BASE | CAPSULE / ORAL | 2020-06-04 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A210575-001 | ATAZANAVIR SULFATE | EQ 150MG BASE | CAPSULE / ORAL | 2020-06-04 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A210575-002 | ATAZANAVIR SULFATE | EQ 200MG BASE | CAPSULE / ORAL | 2020-06-04 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A210575-003 | ATAZANAVIR SULFATE | EQ 300MG BASE | CAPSULE / ORAL | 2020-06-04 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A210575-001 | ATAZANAVIR SULFATE | EQ 150MG BASE | CAPSULE / ORAL | 2020-06-04 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A210575-002 | ATAZANAVIR SULFATE | EQ 200MG BASE | CAPSULE / ORAL | 2020-06-04 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A210575-003 | ATAZANAVIR SULFATE | EQ 300MG BASE | CAPSULE / ORAL | 2020-06-04 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A210575-001 | ATAZANAVIR SULFATE | EQ 150MG BASE | CAPSULE / ORAL | 2020-06-04 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A210575-002 | ATAZANAVIR SULFATE | EQ 200MG BASE | CAPSULE / ORAL | 2020-06-04 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A210575-003 | ATAZANAVIR SULFATE | EQ 300MG BASE | CAPSULE / ORAL | 2020-06-04 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A210575-001 | ATAZANAVIR SULFATE | EQ 150MG BASE | CAPSULE / ORAL | 2020-06-04 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A210575-002 | ATAZANAVIR SULFATE | EQ 200MG BASE | CAPSULE / ORAL | 2020-06-04 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A210575-003 | ATAZANAVIR SULFATE | EQ 300MG BASE | CAPSULE / ORAL | 2020-06-04 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A210575-001 | ATAZANAVIR SULFATE | EQ 150MG BASE | CAPSULE / ORAL | 2020-06-04 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A210575-002 | ATAZANAVIR SULFATE | EQ 200MG BASE | CAPSULE / ORAL | 2020-06-04 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A210575-003 | ATAZANAVIR SULFATE | EQ 300MG BASE | CAPSULE / ORAL | 2020-06-04 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A210575-001 | ATAZANAVIR SULFATE | EQ 150MG BASE | CAPSULE / ORAL | 2020-06-04 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A210575-002 | ATAZANAVIR SULFATE | EQ 200MG BASE | CAPSULE / ORAL | 2020-06-04 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A210575-003 | ATAZANAVIR SULFATE | EQ 300MG BASE | CAPSULE / ORAL | 2020-06-04 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A210575-001 | ATAZANAVIR SULFATE | EQ 150MG BASE | CAPSULE / ORAL | 2020-06-04 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A210575-002 | ATAZANAVIR SULFATE | EQ 200MG BASE | CAPSULE / ORAL | 2020-06-04 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A210575-003 | ATAZANAVIR SULFATE | EQ 300MG BASE | CAPSULE / ORAL | 2020-06-04 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A210575-001 | ATAZANAVIR SULFATE | EQ 150MG BASE | CAPSULE / ORAL | 2020-06-04 | 79d66fd596c7… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2020-11-12 02:37 UTC | 2020-11 | A210575-001 | AB | 1 | c0c555d07b60… |
| 2020-11-12 02:37 UTC | 2020-11 | A210575-002 | AB | 1 | c0c555d07b60… |
| 2020-11-12 02:37 UTC | 2020-11 | A210575-003 | AB | 1 | c0c555d07b60… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 7c996b59-6381-4c0e-9f6a-0ffee7058aba | 59417e87-cf46-4db6-975b-daf9c921098f | 2025-08-23 | 59417e87-cf46-4db6-975b-daf9c921098f |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.


